Free Access
Med Sci (Paris)
Volume 33, Number 3, Mars 2017
Page(s) 345 - 348
Section Nouvelles
Published online 03 April 2017
  1. Breton G. Origine et développement des cellules dendritiques humaines. Med Sci (Paris) 2015 ; 31 : 725–727. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Swiecki M, Colonna M The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol 2015 ; 15 : 471–485. [Google Scholar]
  3. Witko-Sarsat V, Perruche S. La protéinase 3: signal de danger et agent double dans les vascularites. Med Sci (Paris) 2016 ; 32 : 450–452. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Pelletier F, Garnache-Ottou F, Biichle S, et al. Effects of anti-TNF-alpha agents on circulating endothelial-derived and platelet-derived microparticles in psoriasis. Exp Dermatol 2014 ; 23 : 924–925. [CrossRef] [PubMed] [Google Scholar]
  5. Angelot F, Seilles E, Saas P, Garnache-Ottou F. Les microparticules endothéliales : un signal d’alarme pour le système immunitaire ? Med Sci (Paris) 2010 ; 26 : 31–33. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Ceroi A, Delettre FA, Marotel C, et al. The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation. Haematologica 2016 ; 101 : e72–e76. [CrossRef] [PubMed] [Google Scholar]
  7. A-Gonzalez N, Bensinger SJ, Hong C, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 2009 ; 31 : 245–258. [CrossRef] [PubMed] [Google Scholar]
  8. Lee CS, Penberthy KK, Wheeler KM, et al. Boosting apoptotic cell clearance by colonic epithelial cells attenuates inflammation in vivo. Immunity 2016 ; 44 : 807–820. [CrossRef] [PubMed] [Google Scholar]
  9. Pagano L, Valentini CG, Grammatico S, Pulsoni A. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol 2016 ; 174 : 188–202. [CrossRef] [PubMed] [Google Scholar]
  10. Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov 2014 ; 13 : 433–444. [CrossRef] [PubMed] [Google Scholar]
  11. Ito A, Hong C, Rong X, et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. eLife 2015 ; 4 : e08009. [PubMed] [Google Scholar]
  12. Bu DX, Griffin G, Lichtman AH. Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 2011 ; 22 : 165–170. [PubMed] [Google Scholar]
  13. Vasseur S, Guillaumond F. L’adénocarcinome pancréatique : une tumeur dépendante des lipoprotéines. Med Sci (Paris) 2015 ; 31 : 728–730. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Ceroi A, Masson D, Roggy A, et al. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. Blood 2016 ; 128 : 2694–2707. [Google Scholar]
  15. Masson D, Yvan-Charvet L. L’augmentation du HDL-cholestérol : un traitement d’avenir dans le domaine de l’athérosclérose ? Med Sci (Paris) 2008 ; 24 : 341–343. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.